TCL Archive William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position March 4, 1988
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Advisors to NCI are preparing to recommend a “Human Cancer Genome Project” that would create a comprehensive chart of the genetic mutations that cause cancer. The panel also plans to propose an initiative in molecular diagnostics, Eric Lander, director of the Broad Institute, said. September 17, 2004
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010